TOP2A and leukemia: Therefore, TOP2α interfacial inhibitors/poisons (e.g., etoposide, mitoxantrone, and anthracyclines), are efficacious in the treatment of a variety of leukemias, lymphomas, and solid tumors [6,7,8].